Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates.

Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates.

The development of an efficacious Plasmodium falciparum malaria vaccine remains a top priority for global health. Vaccination with irradiated sporozoites is able to provide complete sterile protection through the action of CD8(+) T cells at the liver-stage of infection. However, this method is curre...

Full description

Bibliographic Details
Main Authors:	Longley, R, Salman, A, Cottingham, M, Ewer, K, Janse, C, Khan, S, Spencer, A, Hill, A
Format:	Journal article
Language:	English
Published:	Nature Publishing Group 2015

Similar Items

Malaria vaccines: identifying Plasmodium falciparum liver-stage targets
by: Longley, R, et al.
Published: (2015)

Assessment of the Plasmodium falciparum pre-erythrocytic antigen UIS3 as a potential candidate for a malaria vaccine
by: Longley, R, et al.
Published: (2016)

Pre-clinical development and assessment of viral vectors expressing a fusion antigen of P. falciparum LSA1 and LSAP2 for efficacy against liver-stage malaria
by: Halbroth, B, et al.
Published: (2019)

An in vitro T cell killing assay to assess new Plasmodium falciparum vaccine candidates
by: Longley, R, et al.
Published: (2013)

Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
by: Bliss, C, et al.
Published: (2018)

Development of an in vitro assay and demonstration of Plasmodium berghei liver-stage inhibition by TRAP-specific CD8+ T cells
by: Longley, R, et al.
Published: (2015)

Liver-stage vaccines for malaria
by: Longley, RJ
Published: (2013)

Screening of viral-vectored P. falciparum pre-erythrocytic candidate vaccine antigens using chimeric rodent parasites
by: Kolli, SK, et al.
Published: (2021)

Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3.
by: Aidoo, M, et al.
Published: (2000)

Viral vectors as vaccine platforms: Deployment in sight
by: Rollier, C, et al.
Published: (2011)

Viral vectors as vaccine platforms: deployment in sight.
by: Rollier, C, et al.
Published: (2011)

Progress with viral vectored malaria vaccines: A multi-stage approach involving “unnatural immunity”
by: Ewer, K, et al.
Published: (2015)

The threshold of protection from liver-stage malaria relies on a fine balance between the number of infected hepatocytes and effector CD8+ T cells present in the liver
by: Spencer, A, et al.
Published: (2017)

A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.
by: Prieur, E, et al.
Published: (2004)

Development of novel vaccine candidates and challenge models for Plasmodium vivax
by: Alves, E, et al.
Published: (2014)

Prime and target immunization protects against liver-stage malaria in mice
by: Gola, A, et al.
Published: (2018)

Protection from liver-stage malaria is dependent on a fine balance between the number of infected hepatocytes and effector CD8(+) T-cells
by: Spencer, A, et al.
Published: (2014)

An in vitro assay to measure antibody-mediated inhibition of P. berghei sporozoite invasion against P. falciparum antigens
by: Rodriguez-Galan, A, et al.
Published: (2017)

Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protection.
by: Biswas, S, et al.
Published: (2012)

Development of adjuvanted multi-antigen liver-stage malaria vaccines
by: Halbroth, B
Published: (2016)

Identification of immunodominant responses to the Plasmodium falciparum antigens PfUIS3, PfLSA1 and PfLSAP2 in multiple strains of mice
by: Longley, R, et al.
Published: (2015)

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
by: Dicks, M, et al.
Published: (2011)

A multi-filovirus vaccine candidate: Co-expression of ebola, Sudan, and Marburg antigens in a single vector
by: Sebastian, S, et al.
Published: (2020)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
by: Ewer (nee Russell), K, et al.
Published: (2017)

Viral vectors as vaccine platforms: from immunogenicity to impact
by: Ewer (nee Russell), K, et al.
Published: (2016)

Functional comparison of blood-stage plasmodium falciparum malaria vaccine candidate antigens
by: Illingworth, JJ, et al.
Published: (2019)

EVALUATION OF SIMIAN ADENOVIRAL VECTOR ADCH63 EXPRESSING MSP-1 AS A CANDIDATE BLOOD-STAGE MALARIA VACCINE
by: Goodman, A, et al.
Published: (2009)

Phase Ia clinical evaluation of the plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors
by: Sheehy, S, et al.
Published: (2011)

Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.
by: Sheehy, S, et al.
Published: (2011)

Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference.
by: Forbes, E, et al.
Published: (2011)

CLINICAL EVALUATION OF NEW VIRAL VECTORED VACCINES TARGETING THE PLASMODIUM FALCIPARUM BLOOD-STAGE ANTIGENS; MSP1 AND AMA1
by: Sheehy, S, et al.
Published: (2011)

Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.
by: Spencer, A, et al.
Published: (2014)

Assessment of novel liver-stage vaccines using transgenic rodent malaria parasites
by: Salman, AM
Published: (2014)

New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1.
by: Goodman, A, et al.
Published: (2010)

Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors.
by: Sheehy, S, et al.
Published: (2012)

Immunogenicity of a pre-erythrocytic-stage malaria insert ME-trap encoded by novel simian adenoviral vectors
by: Reyes-Sandoval, A, et al.
Published: (2005)

The role of antigen in the maintenance and localisation of CD8+ T-cells in the context of liver stage malaria
by: Gola, A
Published: (2018)

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates
by: Capone, S, et al.
Published: (2010)

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates.
by: Capone, S, et al.
Published: (2010)

Uncovering the mechanisms of adenovirus vector immunogenicity
by: Dicks, M, et al.
Published: (2013)